Redwood Grove Capital, LLC Catalent, Inc. Transaction History

Redwood Grove Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $2.78 Million - $2.95 Million	-51,800 Reduced 16.81%	256,356 $14.4 Million
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $2.45 Million - $3.45 Million	57,600 Added 22.99%	308,156 $17.4 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $1.33 Million - $1.51 Million	30,000 Added 13.6%	250,556 $11.4 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $1.56 Million - $3.3 Million	49,101 Added 28.64%	220,556 $9.56 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $1.59 Million - $2.6 Million	35,000 Added 25.65%	171,455 $11.3 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $5.65 Million - $11.1 Million	136,455 New	136,455 $6.14 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Redwood Grove Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Grove Capital, LLC with notifications on news.